Agnes Chan heads the Therapeutic Products Branch of the Health Sciences Authority (HSA), which performs the scientific evaluation for marketing approval as well as post-approval variations for new drugs and generic drugs in Singapore. She graduated from the University College London and is a pharmacist by training. She began her career at HSA in 2001 as a clinical evaluator and has held various positions in the different functions of the Health Products Regulation Group, including as deputy director of legislation and director of the Scientific Advisory Office. She is currently director of the Therapeutic Products Branch.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy